Innopharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INNOPHARMA, and what generic and branded alternatives to INNOPHARMA drugs are available?
INNOPHARMA has one approved drug.
There is one tentative approval on INNOPHARMA drugs.
Summary for Innopharma
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| PTAB Cases with Innopharma as petitioner: | See PTAB cases with Innopharma as petitioner |
Drugs and US Patents for Innopharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Innopharma | PROPOFOL | propofol | INJECTABLE;INJECTION | 205576-001 | Sep 16, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
